Friday, July 10, 2026

pharma · Mild/non-serious osteoarthritis (OA) of the knee.

Haleon - Gebro

HALEON AUSTRALIA PTY is a pharma organization headquartered in AU. Primary therapeutic focus areas include Mild/non-serious osteoarthritis (OA) of the knee.. NovaPharmaNews links 3 clinical program(s), 1 drug profile(s),

Fieberbrunn, AU HQ
179 Employees
TGA registrant Type
Company details
Status
Public
HQ
Fieberbrunn, AU
Employees
179
Programs
3
Drugs
9
Patents
0
Clinical program

400314

Phase 1 · other · For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries

400314 for For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries is a Phase 1 program (other) at HALEON AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).

Internal code 400314

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
HALEON AUSTRALIA PTY LTD
Phase
Phase 1
Modality
other
Indication
For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries
Status
active
Trials
1